ILMN NASDAQ
Illumina, Inc.
1W: +4.3%
1M: +2.8%
3M: +43.5%
YTD: +108.0%
1Y: +179.2%
3Y: +140.4%
5Y: -30.6%
$279.47
+8.43 (+3.11%)
After Hours: $276.95 (-2.52, -0.90%)
Weekly Expected Move ±7.6%
$228
$249
$269
$290
$311
Credit Risk of going bust: lower than 69% of companies Debt: 5.8% of company value Bonds: $101.9M held by 175 funds, 69 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.68 (down 99.4%), Illumina, Inc. would be worth roughly what it owes.
Total debt $2.53B against a stock market value of $40.93B.
Distance to default 7.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-28, debt counted $1.25B (short-term plus half of long-term), stock volatility 48.3%; Altman Z'' 3.12. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.68 (down 99.4%), Illumina, Inc. would be worth roughly what it owes.
Total debt $2.53B against a stock market value of $40.93B.
Distance to default 7.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-28, debt counted $1.25B (short-term plus half of long-term), stock volatility 48.3%; Altman Z'' 3.12. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.34
Bullish
4 bullish
3 neutral
1 bearish
Articles (7d)
8
Daily Sentiment (7 Days)
Articles (100)
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
Atlatl Advisers LLC Purchases New Stake in Illumina, Inc. $ILMN
Atlatl Advisers LLC Purchases New Stake in Illumina, Inc. $ILMN
The top-performing S&P 500 stocks YTD have shed almost 7% on average
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?
Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus
First Citizens Bank & Trust Co. Purchases New Shares in Illumina, Inc. $ILMN
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
Illumina, Inc. $ILMN Stake Reduced by Krilogy Financial LLC
Cathie Wood’s Ark weekly recap: cuts SpaceX exposure alongside HOOD, TER, boosts CRWV, VCYT
Top 10 Q3 insider stock sellers led by Nvidia’s Stevens, Jeff Bezos
25 stocks up more than +100% in 2026 as the S&P 500 hits record high
Argent Capital Management LLC Purchases New Holdings in Illumina, Inc. $ILMN
Moderna, Illumina lead healthcare gains in September as medtech drags
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
REGN or ILMN: Which Is the Better Value Stock Right Now?
Is the Options Market Predicting a Spike in Illumina Stock?
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Andra AP fonden Sells 18,006 Shares of Illumina, Inc. $ILMN
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF
3 things to look out for on Monday
Catalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Bank of America Corp DE Takes Position in Illumina, Inc. $ILMN
Illumina (ILMN) is a Top-Ranked Momentum Stock: Should You Buy?
Baird Financial Group Inc. Decreases Position in Illumina, Inc. $ILMN
Amundi Increases Stock Position in Illumina, Inc. $ILMN
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain?
Hsbc Holdings PLC Acquires 33,077 Shares of Illumina, Inc. $ILMN
3 Stocks Soon Joining the S&P 500
3 Promising Genomics Stocks in the Spotlight in 2026
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
Bloom Energy Is Joining the S&P 500: Is the Stock Still a Buy After Its Massive Run?
Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock?
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Are Robots the New Normal? Bet on these ETFs to Invest in the Future
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
Why Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report?
Is This the Right Time to Add PBH Stock to Your Portfolio?
TMO Stock Could Gain Following the Launch of EMPAD G2 Detector
Neogen Surges 102.8% in a Year: What's Driving the Rally?
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Should You Add Illumina Stock to Your Portfolio Now?
Should You Add Teleflex Stock to Your Portfolio Now?
Top Research Reports for Goldman Sachs, TotalEnergies & Prologis
Biondo Investment Advisors LLC Takes $1.87 Million Position in Illumina, Inc. $ILMN
Allworth Financial LP Purchases New Position in Illumina, Inc. $ILMN
BlackRock Inc. Acquires Shares of 19,191,398 Illumina, Inc. $ILMN
BMRN vs. ILMN: Which Stock Is the Better Value Option?
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Analyst Blog Highlights Illumina, Qnity Electronics and nVent Electric
Empowered Funds LLC Increases Stock Holdings in Illumina, Inc. $ILMN
What Makes Illumina (ILMN) a New Strong Buy Stock
Here's Why Illumina (ILMN) is a Strong Momentum Stock
Illumina (ILMN) Q2 2026 Earnings Call Transcript
Illumina, Inc. (ILMN) Hits Fresh High: Is There Still Room to Run?
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
Illumina (ILMN) Q2 2026 Earnings Call Transcript
Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say
Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates
Earnings week ahead: AAPL. MSFT, AMZN, META, XOM, PYPL, CVX, F, KO, ABBV, V, QCOM, BA, MO, SOFI, and more
EXEL vs. ILMN: Which Stock Is the Better Value Option?
Are Medical Stocks Lagging Celldex Therapeutics (CLDX) This Year?
Amova Asset Management Americas Inc. Sells 165,333 Shares of Illumina, Inc. $ILMN
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Illumina, Inc. $ILMN Shares Sold by Bank of New York Mellon Corp
Here's Why Illumina (ILMN) is a Strong Growth Stock
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Stocks Look Shaky, But This Sector is Booming (Biotech)
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know
Illumina Stock Gains 43.7% in 2026: What's Powering the Rally?
Here's Why Illumina (ILMN) is a Strong Momentum Stock
Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs
EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?
Does TNDM Stock Still Deserve a Place in Your Portfolio?
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Should You Continue to Hold ILMN Stock in Your Portfolio?
Prediction: Grail Stock Will Skyrocket to $100 in 1 Year
AZN vs. ILMN: Which Stock Should Value Investors Buy Now?
Here's Why Illumina (ILMN) is a Strong Growth Stock
Biotech breakout: iShares Biotechnology ETF hits all-time high
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
Notable analyst calls this week: Pfizer, AMD and Intel among top picks
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term
Illumina raised to Overweight at J.P. Morgan after customer survey